Best Echinacea for Immune
Top 3 products ranked
Last reviewed May 2026
Clinical dose: 300–1500 mg
Why Echinacea for Immune
Echinacea plays a supporting role in immune. Echinacea is a widely used immune-support herb. ERA-PRIMA 2024 meta-analysis (30 RCTs, n=5652) found 25–32% reduced respiratory infection risk and 40% reduced antibiotic use.
What dose to look for
Clinical studies typically use 300–1500 mg of echinacea. Prevention: 300–500 mg/day standardized extract. Acute treatment: 900–1500 mg/day at cold onset. Products below this range may not deliver meaningful results.
What the research says
Echinacea has moderate clinical evidence for immune benefits. Meta-analyses of 14-30 trials show 25-58% reduced cold risk, but Cochrane found only 'possible weak benefit' Learn more
Clinical research on Echinacea
LOW — Widely used but RCTs are inconsistent; species and preparation matter enormously · 300–500 mg/day (E. purpurea aerial parts extract)
- •Cochrane review (2014, 24 RCTs) found some echinacea products may reduce cold duration and severity, but results were highly inconsistent across trials. No single preparation was reliably effective. PubMed
- •2012 large RCT (719 participants) using E. purpurea found no significant reduction in cold duration or severity compared to placebo. PubMed
- •Three species (E. purpurea, E. angustifolia, E. pallida), different plant parts (aerial, root), and extraction methods create enormous variation between products. This heterogeneity makes the evidence base almost impossible to interpret.
- •Commercial echinacea products show wild inconsistency in active compound content — one analysis found 0–130% of labeled amounts. Without standardization, clinical trial results are hard to generalize to consumer products.
